Clinical trial
St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
NCT00118833 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00118833 |
|---|---|
| Title | St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) |
| Official title | Placebo-Controlled Trial of Hypericum Perforatum in the Treatment of Generalized Social Anxiety Disorder (GSAD) |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety Disorders, Mental Health |
| Intervention type | Drug |
| Interventions | Hypericum perforatum (St. John's wort) |
| Enrollment | 56 |
| Start date | Aug 1, 2002 |
| Completion | Jun 1, 2006 |
| First posted | Jul 12, 2005 |
| Last update posted | Sep 26, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: